Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ATEA-PHARMACEUTICALS-INC-114338425/news/Atea-Pharmaceuticals-Completes-Patient-Enrollment-in-Global-Phase-3-SUNRISE-3-Trial-Evaluating-Oral-46298354/?utm_source=whatsapp&utm_medium=social&utm_campaign=share